WeDosify

About Closed Loop Medicine

Closed Loop Medicine is a clinical-stage digital therapeutics company pioneering a platform that integrates AI-driven, adaptive drug dosing with companion digital software. Its core strategy involves partnering with pharmaceutical companies to develop and commercialize personalized, combination prescription products, with an initial commercial and clinical focus on GLP-1 therapies for obesity and related conditions. The company has launched its first product in the U.S., secured key patents, and is actively building a pipeline in other chronic disease areas like hypertension and insomnia. It operates as a private, venture-backed firm leveraging regulatory designations for its software as a medical device.

Therapeutic Areas